Ferring Pharmaceuticals
biopharmaceuticals
Based in NJ
AI Overview
With $606K in lobbying spend across 11 quarterly filings, Ferring Pharmaceuticals is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2021 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $240K |
| 2022 | $200K |
| 2023 | $166K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Ferring Pharmaceuticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Family Issues, Budget/Appropriations, Defense
Issues pertaining to maternal health and infertility
Issues pertaining to maternal health and infertility access and treatment
Issues pertaining to maternal health and infertility access and treatment
HR 4450 - Access to Infertility Treatment and Care Act
H. Res. 338 - Recognizing that infertility is a widespread problem that
issues pertaining to maternal health and infertility access and treatment HR 4450/S.2352 - Access to Infertility Treatment and Care Act H. Res. 338 - Recognizing that infertility is a widespread probl
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.